Why the study?
Does intravenous Tenecteplase improve clinical outcomes in a patient with severe postpartum pulmonary embolism?
Does intravenous Tenecteplase improve clinical outcomes in a patient with severe postpartum pulmonary embolism?
Off-label use of intravenous Tenecteplase may be an effective rescue therapy for severe postpartum pulmonary embolism presenting with cardiorespiratory collapse.
Answers are grounded in this paper and cite their sources.
May support off-label tenecteplase rescue in severe postpartum PE; case report leaves open prospective confirmation.
A 35-year-old multiparous woman was found unresponsive, tachypnoeic, hypoxic and in shock 4 h postpartum. The ECG revealed S1 Q3 T3, a right bundle branch block pattern and right-axis deviation. The computed tomography of her pulmonary arteries revealed bilateral pulmonary artery thrombosis with dilated right ventricle. She was fibrinolyzed with intravenous Tenecteplase 30 mg bolus. Her saturation and tachypnoea improved and her ECG reverted to sinus rhythm subsequently. We discuss our use of off-label Tenecteplase in postpartum pulmonary embolism and review the literature.
No takes yet. Share an insight, caveat, or question.
Azarisman et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: